再発性多形性膠芽腫(Recurrent Glioblastoma Multiforme (GBM)):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Recurrent Glioblastoma Multiforme (GBM) Overview 8
Therapeutics Development 9
Pipeline Products for Recurrent Glioblastoma Multiforme (GBM) – Overview 9
Pipeline Products for Recurrent Glioblastoma Multiforme (GBM) – Comparative Analysis 10
Recurrent Glioblastoma Multiforme (GBM) – Therapeutics under Development by Companies 11
Recurrent Glioblastoma Multiforme (GBM) – Therapeutics under Investigation by Universities/Institutes 15
Recurrent Glioblastoma Multiforme (GBM) – Pipeline Products Glance 16
Late Stage Products 16
Clinical Stage Products 17
Early Stage Products 18
Recurrent Glioblastoma Multiforme (GBM) – Products under Development by Companies 19
Recurrent Glioblastoma Multiforme (GBM) – Products under Investigation by Universities/Institutes 22
Recurrent Glioblastoma Multiforme (GBM) – Companies Involved in Therapeutics Development 23
Agenus, Inc. 23
Amgen Inc. 24
AngioChem Inc. 25
Apogenix GmbH 26
AstraZeneca PLC 27
Axelar AB 28
Boehringer Ingelheim GmbH 29
Boston Biomedical, Inc. 30
Celldex Therapeutics, Inc. 31
e-Therapeutics plc 32
Eisai Co., Ltd. 33
Eli Lilly and Company 34
EnGeneIC Ltd 35
ERC Belgium SA 36
GenSpera, Inc. 37
GlaxoSmithKline plc 38
GW Pharmaceuticals plc 39
ImmunoCellular Therapeutics, Ltd. 40
Karyopharm Therapeutics, Inc. 41
Merck & Co., Inc. 42
Novartis AG 43
OncoEthix SA 44
Ono Pharmaceutical Co., Ltd. 45
Pfizer Inc. 46
Sangamo BioSciences, Inc. 47
Spectrum Pharmaceuticals, Inc. 48
Threshold Pharmaceuticals, Inc. 49
Tocagen Inc. 50
Vascular Biogenics Ltd. 51
Virttu Biologics Limited 52
ZIOPHARM Oncology, Inc. 53
Recurrent Glioblastoma Multiforme (GBM) – Therapeutics Assessment 54
Assessment by Monotherapy Products 54
Assessment by Combination Products 55
Assessment by Target 56
Assessment by Mechanism of Action 60
Assessment by Route of Administration 63
Assessment by Molecule Type 65
Drug Profiles 67
(GWP-42002 + GWP-42003) – Drug Profile 67
Ad-RTS-IL-12 – Drug Profile 68
afatinib – Drug Profile 70
AMG-595 – Drug Profile 74
ANG-1005 – Drug Profile 76
APG-101 – Drug Profile 78
axitinib – Drug Profile 80
AXL-1717 – Drug Profile 83
AZD-7451 – Drug Profile 85
BBI-608 – Drug Profile 86
BGJ-398 – Drug Profile 89
bosutinib – Drug Profile 90
buparlisib hydrochloride – Drug Profile 92
capmatinib – Drug Profile 96
dacomitinib – Drug Profile 98
Dendritic Cell Therapy for Recurrent Glioblastoma Multiforme – Drug Profile 100
DNX-2401 – Drug Profile 101
doxorubicin – Drug Profile 103
ERC-1671 – Drug Profile 104
erismodegib – Drug Profile 106
ETS-2101 – Drug Profile 109
evofosfamide – Drug Profile 111
G-200 – Drug Profile 118
galunisertib – Drug Profile 120
golvatinib + lenvatinib – Drug Profile 122
HSV-1716 – Drug Profile 124
ICT-121 – Drug Profile 127
lonafarnib – Drug Profile 128
MDNA-55 – Drug Profile 130
mipsagargin – Drug Profile 131
nabiximols – Drug Profile 133
nivolumab – Drug Profile 136
Oncolytic Virus for Oncology – Drug Profile 142
Oncolytic Virus to Target IL-12 for Oncology – Drug Profile 143
ortataxel – Drug Profile 144
OS-2966 – Drug Profile 145
OTX-015 – Drug Profile 146
pazopanib hydrochloride – Drug Profile 148
pembrolizumab – Drug Profile 153
ribociclib – Drug Profile 158
rilotumumab – Drug Profile 161
rindopepimut – Drug Profile 163
SB-313 – Drug Profile 165
selinexor – Drug Profile 166
SGT-53 – Drug Profile 170
TPI-287 – Drug Profile 172
trebananib – Drug Profile 174
Vaccine to Target Carcinoembryonic Antigen for Oncology – Drug Profile 177
vandetanib – Drug Profile 178
VB-111 – Drug Profile 184
vocimagene amiretrorepvec + flucytosine ER – Drug Profile 185
Recurrent Glioblastoma Multiforme (GBM) – Recent Pipeline Updates 187
Recurrent Glioblastoma Multiforme (GBM) – Dormant Projects 274
Recurrent Glioblastoma Multiforme (GBM) – Discontinued Products 275
Recurrent Glioblastoma Multiforme (GBM) – Product Development Milestones 276
Featured News & Press Releases 276
Appendix 283
Methodology 283
Coverage 283
Secondary Research 283
Primary Research 283
Expert Panel Validation 283
Contact Us 283
Disclaimer 284


【レポート販売概要】

■ タイトル:再発性多形性膠芽腫(Recurrent Glioblastoma Multiforme (GBM)):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015
■ 発行日:2015年3月11日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6256IDB
■ 調査対象地域:グローバル
  • TEVAR(胸部大動脈瘤ステントグラフト治療)の世界市場2016-2020
    About thoracic endovascular aneurysm repair (TEVAR) TEVAR is a minimally invasive procedure done to repair thoracic aortic aneurysms (TAAs) with reduced recovery time and improved survival rates. TAAs are usually asymptomatic, but can lead to life-threatening hemorrhage and rupture. It is divided into three categories based on the location of the problem: aortic arch, ascending aortic, and descend …
  • コンプレッサー(圧縮機)の世界市場2016-2020
    About Compressors Compressors are mechanical devices that compress air or gas in a sealed unit and deliver it at the desired pressure levels. Compressors are categorized as air compressors and gas compressors. An air compressor is a device that compresses and pressurizes air and thereby, converts its potential energy into kinetic energy. A gas compressor is a device that reduces the volume of gas …
  • スモールセル及びWi-Fiオフロード
    As mobile data proliferates so too does the demand for capacity and coverage. Many options exist to cope with data surge. Small cell deployment and Wifi offloading are the main ones. Small cells give the opportunity to come closer to the user and to offer a better coverage, indoors or outdoors at low cost. Despite remaining technological hurdles, Wifi is a heavily deployed and cost-effective solut …
  • アプリケーションモダナイゼーションサービス(AMS)の世界市場予測(~2022年)
    The application modernization services market size is expected to grow from USD 6.87 billion in 2017 to USD 16.67 billion by 2022, at a Compound Annual Growth Rate (CAGR) of 19.4% during the forecast period. The major driver for the upsurge in demand for the application modernization services market is the adoption of cloud computing in the application modernization strategy. The major restraining …
  • 世界の艦艇及び水上戦闘艦艇市場(2014-2024):地域別分析
    Synopsis This report offers detailed analysis of the global Naval Vessels and Surface Combatants market over the next ten years, and provides extensive market size forecasts by country and sub sector. It covers the key technological and market trends in the Naval Vessels and Surface Combatants market. Summary "The Global Naval Vessels and Surface Combatants Market 2014-2024 - Country Analysis: Mar …
  • Samra Electric Power Co.:発電所及び企業SWTO分析2015
    Samra Electric Power Co. - Power Plants and SWOT Analysis, 2015 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarize …
  • 実践管理システムの世界市場分析:製品別(統合型、スタンドアロン)、送達モード別(オンプレミス、Webベース、クラウドベース)、コンポーネント別、エンドユーザー別(医師オフィス、薬局、診断研究所)、セグメント予測、2013 – 2024
    The global practice management systems market is expected to reach USD 17.6 billion by 2024, according to the new report by Grand View Research, Inc. Development of value added services, i.e., integration of practice management system with other healthcare IT solutions (EHR, CPOE, Laboratory Information System and others) is anticipated to propel the demand of practice management over the forecast …
  • 世界の飼料用有機微量ミネラル市場(2014-2018)
    TechNavio's analysts forecast the Global Organic Trace Minerals for Animal Feed market to grow at a CAGR of 7.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the higher bioavailability of organic trace minerals than inorganic counterparts. The Global Organic Trace Minerals for Animal Feed market has also been witnessing the increasing usage in pou …
  • 世界のBFSI(銀行・金融サービス・保険)セキュリティ市場:物理的セキュリティ、サイバーセキュリティ
    Over the last few decades, the operating environment of BFSI industry has changed significantly in terms of technological advancements and work flow processes. There has been continuous technological revolution in the banks and financial institutions in the form of ATMs, core banking, e-banking, mobile banking, and consequently many services came into existence such as Real Time Gross Settlement ( …
  • データ品質ツールの世界市場2016-2020
    About Data Quality Tools Data quality tools refer to a wide range of tools required to ensure the quality and dependability of data in several business processes, including core business operations, business intelligence (BI), analytics, and strategic decision-making. Data quality tool vendors offer a wide range of functionalities such as data profiling, monitoring, parsing, standardization, and e …
  • ドア装置の世界市場:スイングドア、引戸、折戸、回転戸
    Consumers have become more concerned with their safety and security which results in the rise in demand for high security doors. Factors such as improving global economy, rapid urbanization, high disposable income, and growing middle class families in emerging countries such as China and India have increased the need for buildings. This in turn will stimulate the demand for door systems market. Th …
  • エポキシ化大豆油(ESBO)の世界市場
    ESBO is majorly used as a plasticizer and stabilizer for PVC compounds and gradually evolved its reach to other application segments. The demand for ESBO is high as it has excellent compatibility and thermal stability. ESBO is being used as the preferred substitute for phthalate plasticizers by major PVC manufacturers and suppliers globally. The North America region is the largest consumer of ESBO …
  • 軍事用拡張現実(MAR)技術の世界市場2016-2026
    Visiongain assesses that the global Military Augmented Reality market will reach $1,311.3m in 2016 with significant prospects for growth. It is therefore critical that your strategic plans are timely and your forecasting plans are in place to take advantage of the business opportunities presented in this brand new study. Visiongain’s report will ensure that you keep informed and ahead of your comp …
  • 世界の医用セラミックス市場2013
    ※当レポートは医用セラミックスのビジネス機会、市場動向、応用分野、市場予測、主要企業概要と戦略、サプライチェーンなどをまとめました。 NanoMarkets believes that medical ceramics represents a major opportunity in the medical materials market over the next few years. They have already established themselves in orthopedic and dental implants; providing a multitude of patients with problem free bone and tooth replacements. Increasingly, prostheses for hip replacement …
  • 広告及びセカンドスクリーン市場
    This report explores how live TV will need to change its advertising practices to handle growing competition from the Internet and protect its status as top mass medium. It compares the way ad revenue is progressing for both TV and the Internet, and looks at the rapid changes in TV viewers' behaviour. The report examines whether live TV needs to borrow certain recipes from the Web, to line up with …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。